Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- Part 1 Assessing and utilizing the diagnostic or prognostic power of biomarkers
- Part 2 Biomarkers of kidney disease and dysfunction
- Part 3 Biomarkers of bone disease and dysfunction
- Part 4 Biomarkers of liver disease and dysfunction
- Part 5 Biomarkers of gastrointestinal disease and dysfunction
- Part 6 Biomarkers in toxicology
- Part 7 Biomarkers of cardiovascular disease and dysfunction
- 31 The impact of biochemical tests on patient management
- 32 Cardiac natriuretic peptides in risk assessment of patients with acute myocardial infarction or congestive heart failure
- 33 Serum markers of inflammation and cardiovascular risk
- 34 The clinical significance of markers of coagulation in acute coronary syndromes
- 35 Endothelin: what does it tell us about myocardial and endothelial dysfunction?
- 36 Homocysteine: a reversible risk factor for coronary heart disease
- 37 Matrix metalloproteinases and their tissue inhibitors
- Part 8 Biomarkers of neurological disease and dysfunction
- Part 9 Biomarkers in transplantation
- Index
32 - Cardiac natriuretic peptides in risk assessment of patients with acute myocardial infarction or congestive heart failure
Published online by Cambridge University Press: 20 August 2009
- Frontmatter
- Contents
- List of contributors
- Preface
- Part 1 Assessing and utilizing the diagnostic or prognostic power of biomarkers
- Part 2 Biomarkers of kidney disease and dysfunction
- Part 3 Biomarkers of bone disease and dysfunction
- Part 4 Biomarkers of liver disease and dysfunction
- Part 5 Biomarkers of gastrointestinal disease and dysfunction
- Part 6 Biomarkers in toxicology
- Part 7 Biomarkers of cardiovascular disease and dysfunction
- 31 The impact of biochemical tests on patient management
- 32 Cardiac natriuretic peptides in risk assessment of patients with acute myocardial infarction or congestive heart failure
- 33 Serum markers of inflammation and cardiovascular risk
- 34 The clinical significance of markers of coagulation in acute coronary syndromes
- 35 Endothelin: what does it tell us about myocardial and endothelial dysfunction?
- 36 Homocysteine: a reversible risk factor for coronary heart disease
- 37 Matrix metalloproteinases and their tissue inhibitors
- Part 8 Biomarkers of neurological disease and dysfunction
- Part 9 Biomarkers in transplantation
- Index
Summary

- Type
- Chapter
- Information
- Biomarkers of DiseaseAn Evidence-Based Approach, pp. 334 - 344Publisher: Cambridge University PressPrint publication year: 2002
- 1
- Cited by